Senior insider sale
Chief Operating Officer at VOYAGER THERAPEUTICS, INC. — senior position signals high conviction
$52.5K
9.59K shares
What this filing means
SWARTZ ROBIN plans to sell 9.59K shares of VOYAGER THERAPEUTICS, INC. valued at approximately $52.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/14/2025ACC: 0001959173-25-000295
Officer· Chief Operating Officer
Since Feb 2022
9.59K
Shares to sell
$52.5K
Approx. market value
3.09K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
1/13/2025
3.09KTotal acquired3.09K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/13/2025 | Restricted Stock Vesting Compensation | 3.09K | — |
| Total | 3.09K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
6.50K
Market value
$36.7K
12/23/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.09K
Market value
$15.7K
1/14/2025
Total
Units
9.59K
Value
$52.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/23/2024 | 6.50K | $36.7K | — | Completed |
| Planned — Approximate Date | ||||
1/14/2025 | 3.09K | $15.7K | NASDAQ | Planned |
| Total | 9.59K | $52.5K | ||